TY  - GEN 
AU  - Pérez-Belmonte, Luis M.
AU  - Torres-Peña, José David
AU  - López-Carmona, María D.
AU  - Ayala-Gutiérrez, M. Mar
AU  - Fuentes-Jiménez, Francisco
AU  - Huerta, Lucía Jorge
AU  - Muñoz, Jaime Alonso
AU  - Rubio-Rivas, Manuel
AU  - Madrazo, Manel
AU  - Garcia, Marcos Guzmán
AU  - Montes, Beatriz Vicente
AU  - Sola, Joaquim Fernández
AU  - Ena, Javier
AU  - Ferrer, Ruth Gonzalez
AU  - Mella Perez, Carmen
AU  - Ripper, Carlos Jorge
AU  - Lecumberri, Jose Javier Napal
AU  - Acedo, Iris El Attar
AU  - Canteli, Susana Plaza
AU  - Cosío, Sara Fuente
AU  - Martínez, Francisco Amorós
AU  - Rodríguez, Begoña Cortés
AU  - Pérez-Martínez, Pablo
AU  - Ramos-Rincón, José Manuel
AU  - Gómez-Huelgas, Ricardo
PY  - 2020
SN  - 1741-7015
UR  - http://hdl.handle.net/20.500.11940/16313
AB  - BACKGROUND: Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital death and each routine at-home glucose-lowering drug both individually and in...
KW  - Pandemics
KW  - Length of Stay
KW  - Drug Therapy
KW  - Hypoglycemic Agents
KW  - Logistic Models
KW  - Respiration
KW  - Coronavirus Infections
KW  - Pneumonia
KW  - Insulin
KW  - Noninvasive Ventilation
KW  - Hospital Mortality
KW  - Dipeptidyl-Peptidase IV Inhibitors
KW  - Hospitalization
KW  - Humans
KW  - Prospective Studies
KW  - Metformin
KW  - Diabetes Mellitus
KW  - Intensive Care Units
KW  - Aged
KW  - Cohort Studies
TI  - Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
DO  - 10.1186/s12916-020-01832-2
KW  - CHUF
VL  - 18
ER  -